<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2020-02-11" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2020-02-11</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.062</td>
<td align="right">0.141</td>
<td align="right">0.000</td>
<td align="right">0.021</td>
<td align="right">0.559</td>
<td align="right">0.928</td>
<td align="right">0.030</td>
<td align="right">0.043</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.092</td>
<td align="right">0.154</td>
<td align="right">0.001</td>
<td align="right">0.049</td>
<td align="right">0.678</td>
<td align="right">0.892</td>
<td align="right">0.055</td>
<td align="right">0.053</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.133</td>
<td align="right">0.164</td>
<td align="right">0.002</td>
<td align="right">0.090</td>
<td align="right">0.730</td>
<td align="right">0.795</td>
<td align="right">0.138</td>
<td align="right">0.067</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.099</td>
<td align="right">0.177</td>
<td align="right">0.000</td>
<td align="right">0.039</td>
<td align="right">0.783</td>
<td align="right">0.854</td>
<td align="right">0.074</td>
<td align="right">0.071</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.159</td>
<td align="right">0.216</td>
<td align="right">0.004</td>
<td align="right">0.079</td>
<td align="right">0.919</td>
<td align="right">0.726</td>
<td align="right">0.146</td>
<td align="right">0.128</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.194</td>
<td align="right">0.226</td>
<td align="right">0.008</td>
<td align="right">0.109</td>
<td align="right">0.935</td>
<td align="right">0.632</td>
<td align="right">0.198</td>
<td align="right">0.170</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.241</td>
<td align="right">0.241</td>
<td align="right">0.012</td>
<td align="right">0.156</td>
<td align="right">0.949</td>
<td align="right">0.514</td>
<td align="right">0.238</td>
<td align="right">0.248</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.146</td>
<td align="right">0.201</td>
<td align="right">0.002</td>
<td align="right">0.080</td>
<td align="right">0.885</td>
<td align="right">0.744</td>
<td align="right">0.154</td>
<td align="right">0.102</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.210</td>
<td align="right">0.237</td>
<td align="right">0.009</td>
<td align="right">0.120</td>
<td align="right">0.953</td>
<td align="right">0.600</td>
<td align="right">0.206</td>
<td align="right">0.194</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.251</td>
<td align="right">0.256</td>
<td align="right">0.010</td>
<td align="right">0.151</td>
<td align="right">0.964</td>
<td align="right">0.514</td>
<td align="right">0.218</td>
<td align="right">0.267</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.302</td>
<td align="right">0.282</td>
<td align="right">0.009</td>
<td align="right">0.202</td>
<td align="right">0.977</td>
<td align="right">0.432</td>
<td align="right">0.216</td>
<td align="right">0.351</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.209</td>
<td align="right">0.221</td>
<td align="right">0.005</td>
<td align="right">0.138</td>
<td align="right">0.940</td>
<td align="right">0.566</td>
<td align="right">0.262</td>
<td align="right">0.172</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.278</td>
<td align="right">0.263</td>
<td align="right">0.012</td>
<td align="right">0.182</td>
<td align="right">0.976</td>
<td align="right">0.458</td>
<td align="right">0.234</td>
<td align="right">0.308</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.321</td>
<td align="right">0.292</td>
<td align="right">0.009</td>
<td align="right">0.218</td>
<td align="right">0.983</td>
<td align="right">0.414</td>
<td align="right">0.212</td>
<td align="right">0.374</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.368</td>
<td align="right">0.321</td>
<td align="right">0.006</td>
<td align="right">0.270</td>
<td align="right">0.992</td>
<td align="right">0.376</td>
<td align="right">0.180</td>
<td align="right">0.444</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the model’s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.192</td>
<td align="right">0.162</td>
<td align="right">0.021</td>
<td align="right">0.142</td>
<td align="right">0.646</td>
<td align="right">0.550</td>
<td align="right">0.289</td>
<td align="right">0.161</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.263</td>
<td align="right">0.201</td>
<td align="right">0.030</td>
<td align="right">0.209</td>
<td align="right">0.791</td>
<td align="right">0.382</td>
<td align="right">0.333</td>
<td align="right">0.285</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.447</td>
<td align="right">0.254</td>
<td align="right">0.068</td>
<td align="right">0.411</td>
<td align="right">0.927</td>
<td align="right">0.147</td>
<td align="right">0.250</td>
<td align="right">0.603</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.529</td>
<td align="right">0.260</td>
<td align="right">0.093</td>
<td align="right">0.521</td>
<td align="right">0.972</td>
<td align="right">0.079</td>
<td align="right">0.198</td>
<td align="right">0.723</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.6-0 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
